期刊文献+

ACOS合并2型糖尿病1例诊治分析 被引量:1

Diagnosis and Treatment of a patient with both ACOS and diabetes mellitus type 2
原文传递
导出
摘要 1病历资料患者男,71岁,因'反复咳嗽、憋气50余年,加重1周'于2015-02-12入院。50余年前开始反复咳嗽、咳痰,多在受凉、闻及'发霉性气味'时诱发,重时可伴憋气、喘鸣,病初经休息或吸入药物等治疗后可缓解,发作间期不影响活动。近10年来发作频繁,劳累、冬春季节亦可诱发或症状加重,活动耐力逐渐下降,间断应用'万托林、茶碱片',病情时有反复。1周前受凉后感喘憋加重,不能平卧。
作者 王聪捷
机构地区 烟台毓璜顶医院
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2016年第S2期49-51,共3页 Chinese Journal of Practical Internal Medicine
关键词 哮喘-慢阻肺重叠综合征 2型糖尿病 asthma COPD overlap syndrome diabetes mellitus type 2
  • 相关文献

参考文献2

二级参考文献19

  • 1Westphal SA,Sarosi GA.Diabetic ditoacidosis associated with pulmonary.Clin Infect Dis,1994,18(6):974-978
  • 2Segado-Soriano A,Lopez-Gonnzalez-Cobos C,Granda-Martin MJ,et al.Infectious pathology in diabetic patients cared for in an emergency department.Am Med Intern,1999,16(1):3-7
  • 3Colquhoun AJ,Nicholson KG,Botha JH,et al.Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes.Epidemiol Infect,1997,119(3):335-341
  • 4Global Strategy for the Diagnosis, Management and Prevention of COPD, GlobalInitiative for Chronic Obstructive Lung Disease (UPDATED 2016)[EB/OL].(2016-02-01)[2016-02-14]. http:// www.goldcopd.org/uploads/users/files/WatermarkedGlobal%20 Strategy%202016(1).pdf.
  • 5de Marco R,Accordini S, Cerveri I, et al. Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm[J]. Am J Respir Crit Care Med,2007,175(1):32-39.
  • 6Burgel PR, Nesme-Meyer P, Chanez P , et al. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects[J]. Chest,2009,135(4):975-982.
  • 7Putcha N, Drummond MB, Connett JE, et al. Chronic productive cough is associated with death in smokers with early COPD[J]. COPD,2014;11(4):451-458.
  • 8Kon SS, Dilaver D, Mittal M, et al. The Clinical COPD Questionnaire: response to pulmonary rehabilitation and minimal clinically important difference[J]. Thorax,2014,69(9):793-798.
  • 9Rossi A, Guerriero M, Corrado A, et al. Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO)[J].Respir Res,2014,15:77.
  • 10Dransfield MT, Feldman G, Korenblat P, et al. Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 meg)versus twice-daily fluticasone propionate/salmeterol (250/50 meg)in COPD patients[J]. Respir Med,2014,108(8):1171-1179.

共引文献206

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部